Metformin, but not glimepiride, improves carotid artery diameter and blood flow in patients with type 2 diabetes mellitus.
about
Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment.Cardiovascular effects of anti-diabetes drugs.Effects of metformin on blood and urine pro-inflammatory mediators in patients with type 2 diabetes.Cardiovascular research in CLINICS.Current Therapies That Modify Glucagon Secretion: What Is the Therapeutic Effect of Such Modifications?
P2860
Metformin, but not glimepiride, improves carotid artery diameter and blood flow in patients with type 2 diabetes mellitus.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Metformin, but not glimepiride ...... with type 2 diabetes mellitus.
@ast
Metformin, but not glimepiride ...... with type 2 diabetes mellitus.
@en
type
label
Metformin, but not glimepiride ...... with type 2 diabetes mellitus.
@ast
Metformin, but not glimepiride ...... with type 2 diabetes mellitus.
@en
prefLabel
Metformin, but not glimepiride ...... with type 2 diabetes mellitus.
@ast
Metformin, but not glimepiride ...... with type 2 diabetes mellitus.
@en
P2093
P2860
P356
P1433
P1476
Metformin, but not glimepiride ...... with type 2 diabetes mellitus.
@en
P2093
Bernardo Leo Wajchenberg
Dalva Marreiro Rocha
Helena Atroch Machado
Marcelo Vieira
Marcia Regina Soares Correia
Maria Elizabeth Rossi da Silva
Maria Rosaria Cunha
Rosa Ferreira dos Santos
Rosa Tsunechiro Fukui
P2860
P304
P356
10.6061/CLINICS/2012(07)03
P577
2012-07-01T00:00:00Z